These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25370833)

  • 21. Angptl2 gene knockdown is critical for abolishing angiotensin II-induced vascular smooth muscle cell proliferation and migration.
    Yang H; Liu J; Chen X; Li G
    Biochem Cell Biol; 2022 Feb; 100(1):59-67. PubMed ID: 34860608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway.
    Miyake H; Nelson C; Rennie PS; Gleave ME
    Endocrinology; 2000 Jun; 141(6):2257-65. PubMed ID: 10830316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-6/signal transducer and activator of transcription 3 promotes prostate cancer resistance to androgen deprivation therapy via regulating pituitary tumor transforming gene 1 expression.
    Huang S; Liu Q; Liao Q; Wu Q; Sun B; Yang Z; Hu X; Tan M; Li L
    Cancer Sci; 2018 Mar; 109(3):678-687. PubMed ID: 29288516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nimotuzumab inhibits epithelial-mesenchymal transition in prostate cancer by targeting the Akt/YB-1/AR axis.
    Hu S; Duan YX; Zhou Q; Wang Y; Lu Q
    IUBMB Life; 2019 Jul; 71(7):928-941. PubMed ID: 30907986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p66Shc protein through a redox mechanism enhances the progression of prostate cancer cells towards castration-resistance.
    Miller DR; Ingersoll MA; Chatterjee A; Baker B; Shrishrimal S; Kosmacek EA; Zhu Y; Cheng PW; Oberley-Deegan RE; Lin MF
    Free Radic Biol Med; 2019 Aug; 139():24-34. PubMed ID: 31100478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ErbB-2 signaling plays a critical role in regulating androgen-sensitive and castration-resistant androgen receptor-positive prostate cancer cells.
    Muniyan S; Chen SJ; Lin FF; Wang Z; Mehta PP; Batra SK; Lin MF
    Cell Signal; 2015 Nov; 27(11):2261-71. PubMed ID: 26257301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ANGPTL2 promotes tumor metastasis in hepatocellular carcinoma.
    Gao L; Ge C; Fang T; Zhao F; Chen T; Yao M; Li J; Li H
    J Gastroenterol Hepatol; 2015 Feb; 30(2):396-404. PubMed ID: 25090954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiopoietin-Like Protein 2 Acts as a Novel Biomarker for Diagnosis and Prognosis in Patients with Esophageal Cancer.
    Ide S; Toiyama Y; Shimura T; Kawamura M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Mohri Y; Kusunoki M
    Ann Surg Oncol; 2015 Aug; 22(8):2585-92. PubMed ID: 25564164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of protein S in castration-resistant prostate cancer-like cells.
    Ning P; Zhong JG; Jiang F; Zhang Y; Zhao J; Tian F; Li W
    Endocr Relat Cancer; 2016 Aug; 23(8):595-607. PubMed ID: 27342144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of erythropoietin and erythropoietin receptor in castration-resistant progression of prostate cancer.
    Ye C; Chen GH; Chen X; Qin SF; Shi MF; Zhou T
    Asian J Androl; 2020; 22(4):422-426. PubMed ID: 31417010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased acid ceramidase expression depends on upregulation of androgen-dependent deubiquitinases, USP2, in a human prostate cancer cell line, LNCaP.
    Mizutani N; Inoue M; Omori Y; Ito H; Tamiya-Koizumi K; Takagi A; Kojima T; Nakamura M; Iwaki S; Nakatochi M; Suzuki M; Nozawa Y; Murate T
    J Biochem; 2015 Oct; 158(4):309-19. PubMed ID: 25888580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiopoietin-like protein 2 regulates endothelial colony forming cell vasculogenesis.
    Richardson MR; Robbins EP; Vemula S; Critser PJ; Whittington C; Voytik-Harbin SL; Yoder MC
    Angiogenesis; 2014 Jul; 17(3):675-83. PubMed ID: 24563071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of LSD1 by Pargyline inhibited process of EMT and delayed progression of prostate cancer in vivo.
    Wang M; Liu X; Guo J; Weng X; Jiang G; Wang Z; He L
    Biochem Biophys Res Commun; 2015 Nov; 467(2):310-5. PubMed ID: 26435505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A.
    Sun T; Wang X; He HH; Sweeney CJ; Liu SX; Brown M; Balk S; Lee GS; Kantoff PW
    Oncogene; 2014 May; 33(21):2790-800. PubMed ID: 23770851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
    Jin Y; Cui Z; Li X; Jin X; Peng J
    Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgens induce a distinct response of epithelial-mesenchymal transition factors in human prostate cancer cells.
    Colditz J; Rupf B; Maiwald C; Baniahmad A
    Mol Cell Biochem; 2016 Oct; 421(1-2):139-47. PubMed ID: 27562825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells.
    McNaughton M; Pitman M; Pitson SM; Pyne NJ; Pyne S
    Oncotarget; 2016 Mar; 7(13):16663-75. PubMed ID: 26934645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiopoietin-Like Protein 2 Expression in Tumor Cells Supports Tumor-Associated Macrophage-Induced Tumor Progression in Esophageal Cancer.
    Horino T; Horiguchi H; Yumoto S; Kadomatsu T; Hara Y; Yagi T; Baba Y; Miyamoto Y; Baba H; Oike Y
    Ann Surg Oncol; 2024 Nov; 31(12):7693-7704. PubMed ID: 38981990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated serum angiopoietin-like protein 2 correlates with the metastatic properties of colorectal cancer: a serum biomarker for early diagnosis and recurrence.
    Toiyama Y; Tanaka K; Kitajima T; Shimura T; Kawamura M; Kawamoto A; Okugawa Y; Saigusa S; Hiro J; Inoue Y; Mohri Y; Goel A; Kusunoki M
    Clin Cancer Res; 2014 Dec; 20(23):6175-86. PubMed ID: 25294915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis.
    Endo M; Nakano M; Kadomatsu T; Fukuhara S; Kuroda H; Mikami S; Hato T; Aoi J; Horiguchi H; Miyata K; Odagiri H; Masuda T; Harada M; Horio H; Hishima T; Nomori H; Ito T; Yamamoto Y; Minami T; Okada S; Takahashi T; Mochizuki N; Iwase H; Oike Y
    Cancer Res; 2012 Apr; 72(7):1784-94. PubMed ID: 22345152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.